We serve 3,3-bis(methoxymethyl)-2,6-dimethylheptane CAS:129228-11-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | Colorless transparent liquid | Conform |
| Assay (GC) | ≥97.5% | 97.9% |
| Water (K.F) | ≤500ppm | 225ppm |
| pH | 7 | Conform |
| Conclusion | Conforms to Factory Standard | |
Contact us for information like 3,3-bis(methoxymethyl)-2,6-dimethylheptane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Heptane, 3,3-bis(methoxymethyl)-2,6-dimethyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,3-bis(methoxymethyl)-2,6-dimethylheptane Use and application,3,3-bis(methoxymethyl)-2,6-dimethylheptane technical grade,usp/ep/jp grade.
Related News: When a new strain emerges that has not yet been identified, as is the case with the current outbreak in China, it temporarily becomes known as a novel coronavirus (nCoV).(Z)-6-(((1aR,3aS,5S,7aS,7bS)-5-acetoxy-1a,4,4,7a-tetramethyloctahydronaphtho[1,2-b]oxiren-7b(1aH)-yl)methylene)-4-hydroxy-5-methyl-3-oxocyclohexa-1,4-dien-1-yl acetate manufacturer INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.5-methoxy-1,1,3-trioxo-1,3-dihydro-1λ6-benzo[d]isothiazole-2-carboxylic acid benzylamide supplier In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.2-Azabicyclo[3.2.1]octan-3-one, 2-hydroxy-1,8,8-trimethyl- vendor According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).
